A request for a class action lawsuit filed in the Montreal courthouse on Monday alleges the manufacturers of a recalled heart medication, valsartan, should pay damages to Quebecers who took the drug.
A recall issued by Health Canada on July 9, 2018, announced that several drugs containing valsartan were contaminated with an impurity: a chemical called nitrosodimethylamine, otherwise known as NDMA.
According to the International Agency for Research on Cancer, NDMA is a potential human carcinogen, which means it could cause cancer with long-term exposure.
Valsartan is a drug used to treat patients with high blood pressure and to prevent heart attacks and strokes. It may also be taken by people who recently had heart failure or a heart attack.
Health Canada advised people taking drugs containing valsartan not to stop taking their medication, but to contact their pharmacist and ask…
Original published: 2018-07-18 16:51:22 Read the full Montreal News here
Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.